U.S. Food and Drug Administration reorganized the Center for Drug Evaluation and Research’s Office of Oncology Drug Products under a new name: Office of Hematology and Oncology Products (OHOP). The new structure comprises four divisions: Division of Hematology Products (DHP), Division of Oncology Products 1 (DOP1), Division of Oncology Products 2 (DOP2), and Division of Hematology Oncology Toxicology (DHOT). Read more.
FDA restructures oncology organization
